Miconazole EP impurity F

IMPURITIES

Product Details

CAT No.# CS-O-07924
Category Impurities
CAS 27220-35-5
Molecular Weight 479.14
Molecular Formula C18H15Cl4N3O4
Stock Status: In-Stock
Purity: >98%
Synonyms: Miconazole EP impurity F;1-[2-(2,4henyl)methoxy]ethyl]-1H-imidazole; nitric acid;1-[2-(2,4-Dichlorophenyl)-2-[(3,4-dichlorophenyl)Methoxy]ethyl]-1H-iMidazole Nitrate;1-[2,4-Dichloro-β-[(3,4-dichlorobenzyl)oxy]phenethyl]iMidazole Mononitrate;3,4-Dichloro Miconazole Nitrate;Miconazole EP IMpurity F
Application Notes: it is an isomer of Miconazole; a 3,4-dichloro-substitution at the benzyl ring. 3,4-Dichlorobenzyl Miconazole is a potent antifungal agent.;Impurity in commercial preparations of Miconazole
References: Rogerson, T.D., et al.: Biochem. Pharmacol., 26, 1039 (1977), Howe, G.A., et al.: Curr. Opin. Plant Biol., 5, 230 (2002), Delker, C., et al.: Plant Biol., 8, 297 (2006),
Storage: 2-8°C
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
8. BISPHENOL AF (RING-13C12)
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F


SMILES:
O=[N](O)=O.ClC1=C(C=CC(Cl)=C1)C(OCC2=CC(Cl)=C(Cl)C=C2)CN3C=CN=C3



This page contains information about Miconazole EP impurity F Cas 27220-35-5 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."